News
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
2d
Axios on MSNFDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...
Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...
A transgender woman incarcerated in Eastern Kentucky is suing the state's prison system over a plan to cut off her ...
Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with ...
Puerto Rico’s governor has signed a bill that prohibits hormone therapy or gender-affirming surgeries for transgender youth, a move that has drawn sharp criticism from activists in the largely ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results